公司资料
LeMaitre Vascular 股价、新闻与催化剂
- 股票代码:
- LMAT
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
82.51 USD (+0.16%)
收盘价
最后更新: 2026年8月17日
2.09B USD
市值
股价为何变动
As of Aug 17, 2026, LMAT was little changed and closed at $82.51. No new same-company headline was identified in the current news window.
公司概览
业务概览
LeMaitre Vascular is a medical device company serving vascular surgeons with implants, grafts, and related products. The business is rooted in procedure-linked vascular care.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, LeMaitre sits in niche medtech.
商业模式特征
Revenue comes from surgeon adoption, recurring product use, and steady growth in vascular procedures.
生物医药行业定位
LeMaitre is a disciplined medtech name that trades on procedural demand and product execution rather than biotech catalysts.
未来催化剂
- LeMaitre's catalysts are vascular-graft demand, biologic patch adoption, and product-cycle execution in specialty surgery. The stock improves when recurring demand stays steady.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。